StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Will we Ever Get an Explanation to This

<< Previous

Bullboard Posts

Next >>

Comment by LithLoveron Oct 04, 2021 3:36pm

80 Views

Post# 33962008

RE:Will we Ever Get an Explanation to This

Why do you care?

Liked2Think wrote: $81.2M dollar combo

Are the shareholders entitled to at least an acknowledgement of what went on or what if anything is going on or will the sheep here continue to accept the excuse by the pumpers that because of covid Oncore should not had generated 1 penny of revenue even with their 62M contract with ibodycheck.

Of all the stuff with what management has said on calls it is what it is but how can you look at this and be fine with it. $82M can be thrown out there, never mentioned again, and you are all fine with it. No wonder you are find with the stock price going lower and lower.